Liu et al. (66) found that LINC00152 improves serum response factor (SRF) expression by sponging miR-125a-5p to activate the MAPK/ERK and Hippo pathways to promote tamoxifen resistance in breast cancer cells. Here, SRF is linked to breast carcinoma.